MBX vs WYNN · $1.98B cap vs P/E 29, rev $3.71B
MBX Biosciences, Inc. Common Stock (MBX) versus Wynn Resorts Limited (WYNN) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Wynn Resorts Limited (WYNN) is a resorts & casinos company listed on NASDAQ.
MBX does not have a complete income-statement cache yet.
Latest reported WYNN revenue for 2026-06-30 was $3.71B. Net income was $260.5M. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
MBX currently screens at market cap $1.98B. WYNN currently screens at market cap $10.62B and trailing P/E 29.3.
Not investment advice. Open the MBX and WYNN stock pages for the full models.
Not investment advice.